Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06337188 · ClinicalTrials.gov registry record · NA
Adaptive and Individualized AAC Phase II
A NA study of Communication Disorders, sponsored by Altec.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06337188 is a NA study of Communication Disorders that is actively recruiting participants, run by Altec. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06337188, a NA study of Communication Disorders, is actively recruiting participants, sponsored by Altec.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by creating a personalized, comprehensive keyboard interface for communication, not otherwise available to people in need of alternative communication.
Conditions Studied
Interventions
- DEVICE Experimental AAC
- DEVICE Generic AAC
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-03 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06337188
The ClinicalTrials.gov registry entry for NCT06337188 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altec, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Communication Disorders appearing as the primary indexed condition, and to 2 interventions - of which Experimental AAC is the first listed.
NCT06337188 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT06337188 about?
NCT06337188 is a clinical study titled "Adaptive and Individualized AAC Phase II". The overall objective of this study is to develop an Augmentative and Alternative Communication (AAC) system that is effective in delivering a person-centric communication device that will provide a versatile access method that can automatically learn and adapt to the user's physical abilities by cr...
What is the current status of trial NCT06337188?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-12-03. Estimated completion is 2026-03-01.
What conditions does trial NCT06337188 study?
This clinical trial studies the following conditions: Communication Disorders.
What interventions are being tested in trial NCT06337188?
The interventions under investigation include: Experimental AAC (DEVICE), Generic AAC (DEVICE).
Who is sponsoring clinical trial NCT06337188?
This trial is sponsored by Altec, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06337188 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.